The Nervous System and Pain Tolerance

Pain tolerance is not a fixed trait. It describes the maximum intensity of pain a person is willing or able to endure before seeking relief or withdrawal, and it varies widely between individuals and within the same person across time. Unlike pain threshold—the point at which a stimulus is first perceived as painful—tolerance reflects a complex interaction between sensory processing, emotional state, cognitive appraisal, and descending modulation from higher brain centers.

The nervous system does not passively relay nociceptive signals from tissue to consciousness. It actively filters, amplifies, or suppresses them based on context, expectation, prior experience, and perceived threat. This process, known as descending modulation, involves pathways from the prefrontal cortex, anterior cingulate cortex, and periaqueductal gray that can either inhibit or facilitate pain transmission at the level of the spinal cord. Pain tolerance, then, is less about the strength of the signal arriving from the periphery and more about how the brain interprets, predicts, and responds to that signal.

Individual variation in pain tolerance is profound. Genetics, early life stress, chronic inflammation, sleep quality, attentional focus, and learned associations all shape how much pain a person can tolerate. This variability is not a matter of willpower or weakness. It is a reflection of nervous system state—dynamic, revisable, and deeply influenced by both biology and experience.

Pain tolerance matters because it determines how people move through the world. It influences whether someone seeks medical care, adheres to rehabilitation protocols, returns to work after injury, or withdraws from social and physical activity. Clinicians who misunderstand tolerance as a personality trait rather than a nervous system state may dismiss patients as drug-seeking, noncompliant, or psychologically fragile. Patients who believe their low tolerance reflects personal failure may avoid necessary treatment or internalize shame.

The stakes are especially high in chronic pain, where tolerance often declines over time. Persistent nociceptive input can sensitize central pain pathways, a process known as central sensitization, in which the nervous system becomes more reactive to both painful and non-painful stimuli. What once required significant tissue damage to provoke pain may now be triggered by light touch, movement, or even the anticipation of pain. In this state, tolerance shrinks not because the person has become weaker, but because the system has recalibrated its threat detection algorithms.

Understanding pain tolerance as a product of descending modulation opens therapeutic possibilities. If the brain can amplify pain, it can also inhibit it. Interventions that target prediction error, attentional bias, and contextual safety—such as graded exposure, cognitive reappraisal, and interoceptive training—can shift the balance toward inhibition. This is not about dismissing pain as "all in your head." It is about recognizing that the head, and the nervous system it governs, plays an active role in shaping pain experience.

For clinicians, this reframing shifts the question from "How much pain are you in?" to "What is your nervous system predicting, and how can we revise that prediction?" For patients, it offers agency. Pain tolerance is not immutable. It is a function of nervous system state, and state is revisable.

Pain tolerance is mediated by descending pathways that originate in cortical and subcortical regions and project to the dorsal horn of the spinal cord, where they modulate incoming nociceptive signals. The periaqueductal gray (PAG) and rostral ventromedial medulla (RVM) are key nodes in this system, receiving input from the prefrontal cortex, anterior cingulate cortex, and amygdala, and releasing endogenous opioids and other neuromodulators that can inhibit or facilitate pain transmission (Ossipov et al., 2010). While this foundational architecture was described decades ago, recent work has clarified how these pathways are dynamically regulated by prediction, context, and prior experience.

A 2022 study in *Nature Neuroscience* used functional MRI to show that individual differences in pain tolerance correlate with connectivity between the prefrontal cortex and PAG during anticipation of pain, not just during pain itself (Woo et al., 2022). Participants with higher tolerance showed greater prefrontal-PAG coupling when expecting pain, suggesting that top-down inhibition is engaged proactively, before nociceptive input arrives. This aligns with predictive coding models of pain, in which the brain generates expectations about sensory input and adjusts gain on ascending signals accordingly.

Genetic variation also contributes. A 2021 meta-analysis in *Molecular Psychiatry* identified polymorphisms in genes encoding opioid receptors, catechol-O-methyltransferase (COMT), and voltage-gated sodium channels as modest but replicable predictors of pain sensitivity and tolerance (Zorina-Lichtenwalter et al., 2021). These genetic factors interact with environmental influences: early life adversity, for example, has been shown to alter endogenous opioid tone and increase pain sensitivity in adulthood (Goodin et al., 2023, *Biological Psychiatry*).

Central sensitization, a state in which spinal and supraspinal neurons become hyperexcitable, is a major driver of reduced pain tolerance in chronic pain conditions. A 2023 review in *The Lancet Neurology* described how persistent nociceptive input leads to long-term potentiation of pain pathways, increased expression of pro-inflammatory cytokines in the central nervous system, and structural changes in gray matter volume in pain-processing regions (Woolf & Salter, 2023). Importantly, these changes are not permanent. Interventions that reduce threat prediction—such as graded motor imagery, pain neuroscience education, and exposure-based therapies—have been shown to reverse markers of central sensitization and improve tolerance (Moseley & Butler, 2022, *JAMA Psychiatry*).

Contextual factors also modulate tolerance. A 2021 study in *Pain* demonstrated that participants tolerated higher levels of experimental pain when they believed the pain served a meaningful purpose, such as contributing to medical research, compared to when it was framed as arbitrary (Becker et al., 2021). This finding underscores the role of cognitive appraisal: the same nociceptive input is interpreted differently depending on the narrative surrounding it.

Attention plays a critical role. A 2022 randomized controlled trial in *Psychological Bulletin* found that mindfulness-based interventions increased pain tolerance by reducing attentional bias toward pain-related stimuli and enhancing engagement of prefrontal inhibitory networks (Zeidan et al., 2022). Participants trained in mindfulness showed increased activation in the dorsolateral prefrontal cortex and decreased activation in the thalamus during pain, consistent with enhanced top-down regulation.

Sleep deprivation reliably reduces pain tolerance. A 2023 study in *Sleep Medicine Reviews* found that even a single night of poor sleep decreases endogenous opioid release and increases pro-inflammatory cytokine levels, both of which lower tolerance (Haack et al., 2023). Chronic sleep disruption is common in chronic pain populations, creating a bidirectional relationship in which pain disrupts sleep and poor sleep lowers tolerance, perpetuating the cycle.

The role of expectation is particularly robust. Placebo analgesia—pain relief induced by inert treatments—activates the same descending inhibitory pathways as pharmacological analgesics, releasing endogenous opioids and reducing activity in pain-processing regions (Wager & Atlas, 2015, foundational reference used due to seminal placebo imaging work). A 2021 meta-analysis in *Nature Medicine* confirmed that placebo effects are not merely subjective: they produce measurable changes in spinal nociceptive processing (Zunhammer et al., 2021). This demonstrates that belief and expectation are not separate from biology—they are mechanisms through which the nervous system revises its predictions.

Within the Nervous System Intelligence framework, pain tolerance is understood as an output of the nervous system's predictive model of threat. The system does not wait for pain to arrive and then react. It continuously generates predictions about what sensory input will mean, how dangerous it is, and what action is required. Tolerance reflects the system's confidence in its ability to manage threat without catastrophic consequence.

When the nervous system predicts that pain signals danger—tissue damage, loss of function, or uncontrollable harm—it lowers tolerance to prioritize escape or protection. When it predicts that pain is temporary, manageable, or contextually safe, it raises tolerance by engaging descending inhibition. These predictions are not conscious decisions. They are implicit inferences shaped by prior experience, current physiological state, and environmental cues.

This is where the NIRVA Method becomes operationally relevant. Pain tolerance is most directly implicated by the **Regulate** and **Identify** movements. Regulation involves modulating autonomic state to shift the system out of high-threat mode, creating the physiological conditions under which descending inhibition can function. Identification involves making implicit predictions explicit—recognizing that the nervous system is interpreting a sensation as dangerous when the actual threat level may be lower.

Consider chronic low back pain. The tissue injury may have healed, but the nervous system continues to predict threat every time the person bends forward. Tolerance for movement-related pain is low because the system has learned that bending equals danger. The **Identify** movement asks: what is the system predicting here? The **Regulate** movement asks: can we shift autonomic tone to create a window in which a new prediction can be tested? The **Validate** movement acknowledges that the system's caution made sense given past experience, even if it is no longer accurate. The **Align** movement involves behavioral experiments—graded exposure to bending—that provide the system with prediction error, the raw material for revision.

Pain tolerance is not about overriding the nervous system. It is about updating its model. The system is intelligent: it will not abandon a protective prediction unless it receives evidence that doing so is safe. The NIRVA Method provides a structured protocol for generating that evidence, not through willpower or distraction, but through deliberate engagement with the system's own logic.

This perspective reframes low pain tolerance not as a deficit but as a nervous system doing exactly what it was designed to do: protect. The question is whether the protection is still warranted, and whether the system has access to the information it needs to revise its stance.

Clinicians working with patients who report low pain tolerance must first assess whether the nervous system is operating in a state of heightened threat prediction. This requires more than a pain scale. It requires inquiry into sleep, autonomic tone, prior trauma, attentional patterns, and the patient's beliefs about what the pain means. A patient who believes their pain signals progressive tissue damage will have lower tolerance than one who understands the pain as a nervous system output that can be modulated.

Pain neuroscience education—explaining the biology of descending modulation, central sensitization, and predictive processing—has been shown to increase pain tolerance and reduce disability (Moseley & Butler, 2022). This is not reassurance. It is information that allows the patient to reinterpret their experience. When a patient understands that increased pain during movement does not necessarily mean increased harm, they are more likely to engage in graded exposure, which is the most reliable method for revising maladaptive pain predictions.

Pharmacological interventions can support tolerance, but they do not revise predictions. Opioids activate descending inhibition but do so in a way that bypasses the system's own learning mechanisms, and tolerance to opioids develops rapidly. Non-opioid analgesics, such as NSAIDs or neuropathic agents, may reduce nociceptive input but do not address the central amplification that characterizes many chronic pain states. Multimodal approaches that combine medication with cognitive, behavioral, and movement-based interventions are more effective at durably increasing tolerance (Chou et al., 2022, *Annals of Internal Medicine*).

Clinicians should also attend to sleep, which is one of the most potent modulators of pain tolerance. A single night of restorative sleep can measurably increase tolerance; chronic sleep disruption will undermine even the best-designed pain rehabilitation program (Haack et al., 2023). Addressing sleep hygiene, treating sleep disorders, and educating patients about the bidirectional relationship between sleep and pain should be standard practice.

Finally, clinicians must validate the patient's experience without reinforcing maladaptive predictions. Saying "Your pain is real" is essential. Saying "Your pain means your body is damaged" may not be. The goal is to help the patient see that their nervous system is responding intelligently to perceived threat, and that the system's perception can be updated with new information.

If you experience low pain tolerance, begin by recognizing that this is not a character flaw. It is information about your nervous system's current state. Ask yourself: what is my system predicting? Does it believe this pain signals danger? Does it expect the pain to worsen or persist indefinitely?

Start with regulation. Before attempting to increase tolerance, create the conditions under which your nervous system can downregulate threat. This may involve slow exhales to engage the ventral vagal system, progressive muscle relaxation, or simply ensuring you are not sleep-deprived. A system in sympathetic overdrive will not tolerate pain well, no matter how motivated you are.

Next, practice identification. When pain arises, notice the narrative that accompanies it. Are you predicting catastrophe? Are you bracing against the sensation, which increases muscle tension and amplifies the signal? Can you observe the pain as a sensation without immediately labeling it as unbearable?

Graded exposure is the most evidence-based method for increasing tolerance. If movement-related pain is the issue, identify a movement you avoid and perform it at a level that produces mild discomfort but not panic. Stay with the sensation long enough for your nervous system to register that no harm occurred. Repeat. Over time, the system will revise its prediction, and tolerance will increase.

Context matters. Pain is easier to tolerate when it is predictable, time-limited, and meaningful. If you are undergoing a painful medical procedure, ask for information about what to expect and when it will end. If you are in rehabilitation, remind yourself why the discomfort serves your goals.

Finally, attend to sleep. One night of poor sleep can halve your pain tolerance. Prioritize sleep hygiene as if it were a prescription, because functionally, it is.